Nanoparticle injection reprograms NK immune cells to fight cancer and autoimmune disorders
MIT engineers have developed a new way to program natural killer (NK) immune cells to target cancerous T cells or T cells that have become autoreactive, leading to diseases such as lymphoma and autoimmune hepatitis.
We haven't written up this one. Phys.org has the full story — the link below goes straight to it.